Jane Messina

Jane Messina, MD

Professor, College of Medicine Pathology & Cell Biology

Professor, Department of Oncologic Sciences

Professor, College of Medicine Dermatology

Academic Email: jmessina@health.usf.edu

Academic Phone:(813) 974-3744

Education

  • MD, University of South Florida, 1988

Recent Publications

  • McCardle TW, Sondak VK, Zager J, Messina JL. Merkel cell carcinoma: pathologic findings and prognostic factors. Current problems in cancer. 34(1) : 47-64http://www.ncbi.nlm.nih.gov/pubmed/20371074
  • Hamill JR, Messina JL. Merkel cell carcinoma: selected clinical cases. Current problems in cancer. 34(1) : 118-23http://www.ncbi.nlm.nih.gov/pubmed/20371079
  • Vyas NS, Markow M, Prieto-Granada C, Gaudi S, Turner L, Rodriguez-Waitkus P, Messina JL, Jukic DM. Comparing whole slide digital images versus traditional glass slides in the detection of common microscopic features seen in dermatitis. Journal of Pathology Informatics. 7: 30, 2016. http://www.ncbi.nlm.nih.gov/pubmed/27563489
  • Pierce Campbell CM, Gheit T, Tommasino M, Lin HY, Torres BN, Messina JL, Stoler MH, Rollison DE, Sirak BA, Abrahamsen M, Carvalho da Silva RJ, Sichero L, Villa LL, Lazcano-Ponce E, Giuliano AR. Cutaneous beta human papillomaviruses and the development of male external genital lesions: A case-control study nested within the HIM Study. Virology. 497: 314-22, 2016. http://www.ncbi.nlm.nih.gov/pubmed/27518539
  • Sherrill AM, Crespo G, Prakash AV, Messina JL. Desmoplastic nevus: An entity distinct from spitz nevus and blue nevus. The American Journal of dermatopathology. 33(1) : 35-9, 2011. http://www.ncbi.nlm.nih.gov/pubmed/21124206
  • Agarwala SS, di Pietro A, Flaherty KT, Garbe C, Grob JJ, Kashani-Sabet M, Kirkwood JM, Leachman S, Messina J, O'Day S, Ribas A, Sondak V. Meeting report from the Third Global Workshop on Melanoma. Pigment cell & melanoma research. 23(5) : e1-7, 2010. http://www.ncbi.nlm.nih.gov/pubmed/20718940
  • Chu CK, Zager JS, Marzban SS, Gimbel MI, Murray DR, Hestley AC, Messina JL, Sondak VK, Carlson GW, Delman KA. Routine biopsy of Cloquet's node is of limited value in sentinel node positive melanoma patients. Journal of surgical oncology. 102(4) : 315-20, 2010. http://www.ncbi.nlm.nih.gov/pubmed/20740592
  • Paraiso KH, Van Der Kooi K, Messina JL, Smalley KS. Measurement of constitutive MAPK and PI3K/AKT signaling activity in human cancer cell lines. Methods in enzymology. 484: 549-67, 2010. http://www.ncbi.nlm.nih.gov/pubmed/21036250
  • Smithberger ES, Rezania D, Chavan RN, Lien MH, Cualing HD, Messina JL. Primary cutaneous angioimmunoblastic T-cell lymphoma histologically mimicking an inflammatory dermatosis. Journal of drugs in dermatology : JDD. 9(7) : 851-5, 2010. http://www.ncbi.nlm.nih.gov/pubmed/20677543
  • Sarnaik AA, Zager JS, Cox LE, Ochoa TM, Messina JL, Sondak VK. Routine omission of sentinel lymph node biopsy for merkel cell carcinoma <= 1 cm is not justified. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(1) : e7, 2010. http://www.ncbi.nlm.nih.gov/pubmed/19933899
  • Santillan AA, Messina JL, Marzban SS, Crespo G, Sondak VK, Zager JS. Pathology review of thin melanoma and melanoma in situ in a multidisciplinary melanoma clinic: impact on treatment decisions. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(3) : 481-6, 2010. http://www.ncbi.nlm.nih.gov/pubmed/20008627
  • Messina JL, Sondak VK. Refining the criteria for sentinel lymph node biopsy in patients with thinner melanoma: a roadmap for the future. Cancer. 116(6) : 1403-5, 2010. http://www.ncbi.nlm.nih.gov/pubmed/20091836
  • Casper DJ, Ross KI, Messina JL, Sondak VK, Bodden CN, McCardle TW, Glass LF. Useof anti-phosphohistone H3 immunohistochemistry to determine mitotic rate in thin melanoma. The American Journal of dermatopathology. 32(7) : 650-4, 2010. http://www.ncbi.nlm.nih.gov/pubmed/20559123
  • Farma JM, Ammori JB, Zager JS, Marzban SS, Bui MM, Bichakjian CK, Johnson TM, Lowe L, Sabel MS, Wong SL, Douglas Letson G, Messina JL, Cimmino VM, Sondak VK. Dermatofibrosarcoma protuberans: how wide should we resect? Annals of surgical oncology. 17(8) : 2112-8, 2010. http://www.ncbi.nlm.nih.gov/pubmed/20354798
  • Agarwala SS, Becker JC, Eggermont AM, Flaherty KT, Garbe C, Goldstein AM, Halpern A, Kashani-Sabet M, Hauschild A, Kirkwood JM, Leachman S, Lorigan P, McMahon M, Messina J, Ribas A, Samlowski WE, Schadendorf D, Sondak VK. Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008. Pigment cell & melanoma research. 22(5) : 532-43, 2009. http://www.ncbi.nlm.nih.gov/pubmed/19659612
  • Messina J, Möller MG, Sondak VK, Frank Glass L, Wayne Cruse C. The contoured staged marginal and central surgical excision technique with en face histopathological analysis: useful additions in the armamentarium for treating and diagnosing melanoma in situ. Annals of surgical oncology. 16(9) : 2654-5, 2009. http://www.ncbi.nlm.nih.gov/pubmed/19588203
  • McCardle TW, Messina JL, Sondak VK. Completely regressed cutaneous melanocytic lesion revisited. Seminars in oncology. 36(6) : 498-503, 2009. http://www.ncbi.nlm.nih.gov/pubmed/19995640
  • Mills O, Messina JL. Pediatric melanoma: a review. Cancer control : journal of the Moffitt Cancer Center. 16(3) : 225-33, 2009. http://www.ncbi.nlm.nih.gov/pubmed/19556962
  • Dissanayake SK, Olkhanud PB, O'Connell MP, Carter A, French AD, Camilli TC, Emeche CD, Hewitt KJ, Rosenthal DT, Leotlela PD, Wade MS, Yang SW, Brant L, Nickoloff BJ, Messina JL, Biragyn A, Hoek KS, Taub DD, Longo DL, Sondak VK, Hewitt SM, Weeraratna AT. Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation. Cancer research. 68(24) : 10205-14, 2008. http://www.ncbi.nlm.nih.gov/pubmed/19074888
  • Sagatys EM, Messina JL, Rojiani AM. 55-year-old man with a paraspinal mass. Brain pathology (Zurich, Switzerland). 18(4) : 631-5, 2008. http://www.ncbi.nlm.nih.gov/pubmed/18782182
  • Rollison DE, Pawlita M, Giuliano AR, Iannacone MR, Sondak VK, Messina JL, Cruse CW, Fenske NA, Glass LF, Kienstra M, Michael KM, Waterboer T, Gheit T, Tommasino M. Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers. International journal of cancer. Journal international du cancer. 123(10) : 2337-42, 2008. http://www.ncbi.nlm.nih.gov/pubmed/18729188
  • Clark GS, Pappas-Politis EC, Cherpelis BS, Messina JL, Möller MG, Cruse CW, Glass LF. Surgical management of melanoma in situ on chronically sun-damaged skin. Cancer control : journal of the Moffitt Cancer Center. 15(3) : 216-24, 2008. http://www.ncbi.nlm.nih.gov/pubmed/18596673
  • Messina JL, Yu H, Riker AI, Munster PN, Jove RL, Daud AI. Activated stat-3 in melanoma. Cancer control : journal of the Moffitt Cancer Center. 15(3) : 196-201, 2008. http://www.ncbi.nlm.nih.gov/pubmed/18596671
  • Zager JS, Bui MM, Farma JM, Messina JL, Sondak VK. Proper margins of excision in dermatofibrosarcoma protuberans: wide or narrow? Annals of surgical oncology. 15(9) : 2614-6, 2008. http://www.ncbi.nlm.nih.gov/pubmed/18452044
  • Barnhill RL, Argenyi Z, Berwick M, Duray PH, Erickson L, Guitart J, Horenstein MG, Lowe L, Messina J, Paine S, Piepkorn MW, Prieto V, Rabkin MS, Schmidt B, Selim A, Shea CR, Trotter MJ. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus"). The American journal of surgical pathology. 32(1) : 36-44, 2008. http://www.ncbi.nlm.nih.gov/pubmed/18162768
  • Fishman M, Hunter TB, Soliman H, Thompson P, Dunn M, Smilee R, Farmelo MJ, Noyes DR, Mahany JJ, Lee JH, Cantor A, Messina J, Seigne J, Pow-Sang J, Janssen W, Antonia SJ. Phase II trial of B7-1 (CD-86) transduced, cultured autologous tumor cell vaccine plus subcutaneous interleukin-2 for treatment of stage IV renal cell carcinoma. Journal of immunotherapy (Hagerstown, Md. : 1997). 31(1) : 72-80, 2008. http://www.ncbi.nlm.nih.gov/pubmed/18157014
  • Sondak VK, Messina JL. Lymphangiogenesis: host and tumor factors in nodal metastasis. Archives of dermatology. 144(4) : 536-7, 2008. http://www.ncbi.nlm.nih.gov/pubmed/18427050
  • Dessureault S, Noyes D, Lee D, Dunn M, Janssen W, Cantor A, Sotomayor E, Messina J, Antonia SJ. A phase-I trial using a universal GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) in the formulation of autologous tumor cell-based vaccines for cancer patients with stage IV disease. Annals of surgical oncology. 14(2) : 869-84, 2007. http://www.ncbi.nlm.nih.gov/pubmed/17103257
  • Patrick RJ, Fenske NA, Messina JL. Primary mucosal melanoma. Journal of the American Academy of Dermatology. 56(5) : 828-34, 2007. http://www.ncbi.nlm.nih.gov/pubmed/17349716
  • Jensen EH, Lewis JM, McLoughlin JM, Alvarado MD, Daud A, Messina J, Enkemann S, Yeatman TJ, Sondak VK, Riker AI. Down-regulation of pro-apoptotic genes is an early event in the progression of malignant melanoma. Annals of surgical oncology. 14(4) : 1416-23, 2007. http://www.ncbi.nlm.nih.gov/pubmed/17195911
  • Sondak VK, Zager JS, Messina JL, Thomas JM. Sentinel lymph node biopsy as the standard of care for cutaneous melanoma. Clinical advances in hematology & oncology : H&O. 5(6) : 483-90, 2007. http://www.ncbi.nlm.nih.gov/pubmed/17679922
  • Hightower C, Messina JL. Cutaneous Protothecosis: Case Description and Review of the Literature Cutis.. 80: 129-131, 2007.
  • Shors AR, Kim S, White E, Argenyi Z, Barnhill RL, Duray P, Erickson L, Guitart J, Horenstein MG, Lowe L, Messina J, Rabkin MS, Schmidt B, Shea CR, Trotter MJ, Piepkorn MW. Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma. The British journal of dermatology. 155(5) : 988-93, 2006. http://www.ncbi.nlm.nih.gov/pubmed/17034530
  • Baldwin BT, Prakash A, Fenske NA, Messina JL. Aquagenic syringeal acrokeratoderma: report of a case with histologic findings. Journal of the American Academy of Dermatology. 54(5) : 899-902, 2006. http://www.ncbi.nlm.nih.gov/pubmed/16635679
  • Chang SJ, Sims J, Murtagh FR, McCaffrey JC, Messina JL. Proliferating trichilemmal cysts of the scalp on CT. AJNR. American journal of neuroradiology. 27(3) : 712-4, 2006. http://www.ncbi.nlm.nih.gov/pubmed/16552022
  • Homsi J, Kashani-Sabet M, Messina JL, Daud A. Cutaneous melanoma: prognostic factors. Cancer control : journal of the Moffitt Cancer Center. 12(4) : 223-9, 2005. http://www.ncbi.nlm.nih.gov/pubmed/16258493
  • Puleo CA, Messina JL, Riker AI, Glass LF, Nelson C, Cruse CW, Johnson TM, Sondak VK. Sentinel node biopsy for thin melanomas: which patients should be considered? Cancer control : journal of the Moffitt Cancer Center. 12(4) : 230-5, 2005. http://www.ncbi.nlm.nih.gov/pubmed/16258494
  • Riker AI, Glass F, Perez I, Cruse CW, Messina J, Sondak VK. Cutaneous melanoma: methods of biopsy and definitive surgical excision. Dermatologic therapy. 18(5) : 387-93, 2005. http://www.ncbi.nlm.nih.gov/pubmed/16297013
  • Munn DH, Sharma MD, Hou D, Baban B, Lee JR, Antonia SJ, Messina JL, Chandler P, Koni PA, Mellor AL. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. The Journal of clinical investigation. 114(2) : 280-90, 2004. http://www.ncbi.nlm.nih.gov/pubmed/15254595
  • Naing A, Messina JL, Vrionis FR, Daud AI. Uncommon manifestations of common malignancies: case 3. Malignant melanoma arising from a spinal nerve root. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 22(15) : 3194-5, 2004. http://www.ncbi.nlm.nih.gov/pubmed/15284274
  • Bickle K, Glass LF, Messina JL, Fenske NA, Siegrist K. Merkel cell carcinoma: a clinical, histopathologic, and immunohistochemical review. Seminars in cutaneous medicine and surgery. 23(1) : 46-53, 2004. http://www.ncbi.nlm.nih.gov/pubmed/15095915
  • Sackstein R, Messina JL, Elfenbein GJ. In vitro adherence of lymphocytes to dermal endothelium under shear stress: implications in pathobiology and steroid therapy of acute cutaneous GVHD. Blood. 101(2) : 771-8, 2003. http://www.ncbi.nlm.nih.gov/pubmed/12393384
  • Lee JR, Dalton RR, Messina JL, Sharma MD, Smith DM, Burgess RE, Mazzella F, Antonia SJ, Mellor AL, Munn DH. Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma. Laboratory investigation; a journal of technical methods and pathology. 83(10) : 1457-66, 2003. http://www.ncbi.nlm.nih.gov/pubmed/14563947
  • Reschly MJ, Messina JL, Zaulyanov LL, Cruse W, Fenske NA. Utility of sentinel lymphadenectomy in the management of patients with high-risk cutaneous squamous cell carcinoma. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 29(2) : 135-40, 2003. http://www.ncbi.nlm.nih.gov/pubmed/12562341
  • Castellano-Howard L, Fairbee SI, Hogan DJ, Fenske NA, Messina JL. Extrafacial granuloma faciale: report of a case and response to treatment. Cutis; cutaneous medicine for the practitioner. 67(5) : 413-5, 2001. http://www.ncbi.nlm.nih.gov/pubmed/11381859
  • Shivers SC, Li W, Lin J, Stall A, Stafford M, Messina J, Glass LF, Reintgen DS. The clinical relevance of molecular staging for melanoma. Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer. 158: 187-99, 2001. http://www.ncbi.nlm.nih.gov/pubmed/11092046
  • Cherpelis BS, Haddad F, Messina J, Cantor AB, Fitzmorris K, Reintgen DS, Fenske NA, Glass LF. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas. Journal of the American Academy of Dermatology. 44(5) : 762-6, 2001. http://www.ncbi.nlm.nih.gov/pubmed/11312421
  • Smith DF, Messina JL, Perrott R, Berman CG, Reintgen DS, Cruse CW, Glass FL, Fenske NA, DeConti RC, Trotti A. Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Cancer control : journal of the Moffitt Cancer Center. 7(1) : 72-83, 2000. http://www.ncbi.nlm.nih.gov/pubmed/10740663
  • Flannery MT, Chapman V, Cruz-Gonzales I, Rivera M, Messina JL. Ileal perforation secondary to histoplasmosis in AIDS. The American journal of the medical sciences. 320(6) : 406-7, 2000. http://www.ncbi.nlm.nih.gov/pubmed/11149555
  • Byrd-Gloster AL, Khoor A, Glass LF, Messina JL, Whitsett JA, Livingston SK, Cagle PT. Differential expression of thyroid transcription factor 1 in small cell lung carcinoma and Merkel cell tumor. Human pathology. 31(1) : 58-62, 2000. http://www.ncbi.nlm.nih.gov/pubmed/10665914
  • Haddad FF, Stall A, Messina J, Brobeil A, Ramnath E, Glass LF, Cruse CW, Berman CG, Reintgen DS. The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion. Annals of surgical oncology. 6(2) : 144-9, 1999. http://www.ncbi.nlm.nih.gov/pubmed/10082038
  • Messina JL, Glass LF, Cruse CW, Berman C, Ku NK, Reintgen DS. Pathologic examination of the sentinel lymph node in malignant melanoma. The American journal of surgical pathology. 23(6) : 686-90, 1999. http://www.ncbi.nlm.nih.gov/pubmed/10366151
  • Kamath D, Brobeil A, Stall A, Lyman G, Cruse CW, Glass F, Fenske N, Messina J, Berman C, Reintgen D. Cutaneous lymphatic drainage in patients with grossly involved nodal basins. Annals of surgical oncology. 6(4) : 345-9, 1999. http://www.ncbi.nlm.nih.gov/pubmed/10379854
  • Goscin C, Glass LF, Messina JL. Pathologic examination of the sentinel lymph node in melanoma. Surgical oncology clinics of North America. 8(3) : 427-34, viii, 1999. http://www.ncbi.nlm.nih.gov/pubmed/10448687
  • Brobeil A, Cruse CW, Messina JL, Glass LF, Haddad FF, Berman CG, Marshburn J, Reintgen DS. Cost analysis of sentinel lymph node biopsy as an alternative to elective lymph node dissection in patients with malignant melanoma. Surgical oncology clinics of North America. 8(3) : 435-45, viii, 1999. http://www.ncbi.nlm.nih.gov/pubmed/10448688
  • Pu LL, Cruse CW, Wells KE, Cantor A, Glass LF, Messina JL, Reintgen DS. Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma of the lower extremity. Plastic and reconstructive surgery. 104(4) : 964-9, 1999. http://www.ncbi.nlm.nih.gov/pubmed/10654734
  • Lipp KE, Shenefelt PD, Nelson RP, Messina JL, Fenske NA. Persistent Sweet's syndrome occurring in a child with a primary immunodeficiency. Journal of the American Academy of Dermatology. 40(5 Pt 2) : 838-41, 1999. http://www.ncbi.nlm.nih.gov/pubmed/10321630
  • Shivers SC, Wang X, Li W, Joseph E, Messina J, Glass LF, DeConti R, Cruse CW, Berman C, Fenske NA, Lyman GH, Reintgen DS. Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA : the journal of the American Medical Association. 280(16) : 1410-5, 1998. http://www.ncbi.nlm.nih.gov/pubmed/9801000
  • Joseph E, Brobeil A, Glass F, Glass J, Messina J, DeConti R, Cruse CW, Rapaport DP, Berman C, Fenske N, Reintgen DS. Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Annals of surgical oncology. 5(2) : 119-25, 1998. http://www.ncbi.nlm.nih.gov/pubmed/9527264
  • Heller R, Jaroszeski M, Perrott R, Messina J, Gilbert R. Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma research. 7(1) : 10-8, 1997. http://www.ncbi.nlm.nih.gov/pubmed/9067960
  • Brobeil A, Rapaport D, Wells K, Cruse CW, Glass F, Fenske N, Albertini J, Miliotis G, Messina J, DeConti R, Berman C, Shons A, Cantor A, Reintgen DS. Multiple primary melanomas: implications for screening and follow-up programs for melanoma. Annals of surgical oncology. 4(1) : 19-23, 1997. http://www.ncbi.nlm.nih.gov/pubmed/8985513
  • Messina JL, Glass LF. Pathologic examination of the sentinel lymph node. The Journal of the Florida Medical Association. 84(3) : 153-6, 1997. http://www.ncbi.nlm.nih.gov/pubmed/9143165
  • Brobeil A, Kamath D, Cruse CW, Rapaport DP, Wells KE, Shons AR, Messina JL, Glass LF, Berman CG, Puleo CA, Reintgen DS. The clinical relevance of sentinel lymph nodes identified with radiolymphoscintigraphy. The Journal of the Florida Medical Association. 84(3) : 157-60, 1997. http://www.ncbi.nlm.nih.gov/pubmed/9143166
  • Kamath D, Cantor AB, Glass F, Fenske N, Cruse CW, Wells K, Rapaport D, DeConti R, Messina J, Reintgen D. Florida's undeclared epidemic: malignant melanoma. The Journal of the Florida Medical Association. 84(3) : 161-5, 1997. http://www.ncbi.nlm.nih.gov/pubmed/9143167
  • Le AD, Fenske NA, Glass LF, Messina JL. Malignant melanoma: differential diagnosis of pigmented lesions. The Journal of the Florida Medical Association. 84(3) : 166-74, 1997. http://www.ncbi.nlm.nih.gov/pubmed/9143168
  • Kamath D, Rapaport D, DeConti R, Cruse CW, Wells K, Glass F, Messina J, Fenske N, Brobeil A, Berman C, Puleo C, Reintgen D. Redefining cutaneous lymphatic flow: the necessity of preoperative lymphoscintigraphy in the management of malignant melanoma. The Journal of the Florida Medical Association. 84(3) : 182-7, 1997. http://www.ncbi.nlm.nih.gov/pubmed/9143170
  • Maurtua MA, Moscinski LC, Messina J, Miller L, Ballester OF. Type III hypersensitivity reaction with the use of interferon-alpha. American journal of hematology. 55(1) : 53-4, 1997. http://www.ncbi.nlm.nih.gov/pubmed/9136924
  • Ramnath EM, Kamath D, Brobeil A, Stall A, Kamath V, Cruse CW, Glass F, Messina J, Fenske N, Berman C, Ross ML, Cantor A, Cuthbertson D, Reintgen DS. Lymphatic Mapping for Melanoma: Long-term Results of Regional Nodal Sampling With Radioguided Surgery. Cancer control : journal of the Moffitt Cancer Center. 4(6) : 483-490, 1997. http://www.ncbi.nlm.nih.gov/pubmed/10763056
  • Dalton JA, Yag-Howard C, Messina JL, Glass LF. Cutaneous T-cell lymphoma. International journal of dermatology. 36(11) : 801-9, 1997. http://www.ncbi.nlm.nih.gov/pubmed/9427070
  • Joseph E, Messina J, Glass FL, Cruse CW, Rapaport DP, Berman C, Reintgen DS. Radioguided surgery for the ultrastaging of the patient with melanoma. The cancer journal from Scientific American. 3(6) : 341-5, 1997. http://www.ncbi.nlm.nih.gov/pubmed/9403046
  • Fotopoulos TN, Shenefelt PD, Messina J. Anaplastic large cell lymphoma mimicking noduloulcerative tertiary syphilis. Cutis; cutaneous medicine for the practitioner. 60(4) : 211-4, 1997. http://www.ncbi.nlm.nih.gov/pubmed/9347238
  • Cruse CW, Reintgen D, Glass F, Messina J, Trotti A, DeConti R, Wells K. Neuroendocrine Carcinoma of the Skin. Cancer control : journal of the Moffitt Cancer Center. 4(4) : 346-348, 1997. http://www.ncbi.nlm.nih.gov/pubmed/10763041
  • Messina JL, Reintgen DS, Cruse CW, Rappaport DP, Berman C, Fenske NA, Glass LF. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Annals of surgical oncology. 4(5) : 389-95, 1997. http://www.ncbi.nlm.nih.gov/pubmed/9259965
  • Messina JL, Yag-Howard C, Fenske NA. Cutaneous hyperpigmentation due to Quinidine Gluconate J Geriatr Dermatol. 4(6) : 198-201, 1996.
  • Miliotes G, Albertini J, Berman C, Heller R, Messina J, Glass F, Cruse W, Rapaport D, Puleo C, Fenske N, Petsoglou C, Deconti R, Lyman G, Reintgen D. The tumor biology of melanoma nodal metastases. The American surgeon. 62(1) : 81-8, 1996. http://www.ncbi.nlm.nih.gov/pubmed/8540654
  • Albertini JJ, Cruse CW, Rapaport D, Wells K, Ross M, DeConti R, Berman CG, Jared K, Messina J, Lyman G, Glass F, Fenske N, Reintgen DS. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Annals of surgery. 223(2) : 217-24, 1996. http://www.ncbi.nlm.nih.gov/pubmed/8597518
  • Heller R, Jaroszeski MJ, Glass LF, Messina JL, Rapaport DP, DeConti RC, Fenske NA, Gilbert RA, Mir LM, Reintgen DS. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer. 77(5) : 964-71, 1996. http://www.ncbi.nlm.nih.gov/pubmed/8608491
  • Glass LF, Fotopoulos T, Messina JL. A generalized cutaneous reaction induced by granulocyte colony-stimulating factor. Journal of the American Academy of Dermatology. 34(3) : 455-9, 1996. http://www.ncbi.nlm.nih.gov/pubmed/8609259
  • Glass LF, Messina JL, Cruse W, Wells K, Rapaport D, Miliotes G, Berman C, Reintgen D, Fenske NA. The use of intraoperative radiolymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 22(8) : 715-20, 1996. http://www.ncbi.nlm.nih.gov/pubmed/8780765
  • Norman JG, Fink GW, Messina J, Carter G, Franz MG. Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis. Surgery. 120(3) : 515-21, 1996. http://www.ncbi.nlm.nih.gov/pubmed/8784406
  • Lipp KE, Smith JB, Brandt TP, Messina JL. Reflex sympathetic dystrophy with mutilating ulcerations suspicious of a factitial origin. Journal of the American Academy of Dermatology. 35(5 Pt 2) : 843-5, 1996. http://www.ncbi.nlm.nih.gov/pubmed/8912601
  • Stadelmann WK, Cruse CW, Messina J. Synovial cell sarcoma of the temporomandibular joint. Annals of plastic surgery. 35(6) : 664-8, 1995. http://www.ncbi.nlm.nih.gov/pubmed/8748354
  • Godellas CV, Berman CG, Lyman G, Cruse CW, Rapaport D, Heller R, Wang X, Glass F, Fenske N, Messina J. The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases. The American surgeon. 61(2) : 97-101, 1995. http://www.ncbi.nlm.nih.gov/pubmed/7856986
  • Norman J, Franz M, Messina J, Riker A, Fabri PJ, Rosemurgy AS, Gower WR. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery. 117(6) : 648-55, 1995. http://www.ncbi.nlm.nih.gov/pubmed/7539942
  • Vesper JL, Messina J, Glass LF, Fenske NA. Profound proliferating pearly penile papules. International journal of dermatology. 34(6) : 425-6, 1995. http://www.ncbi.nlm.nih.gov/pubmed/7657443
  • Norman JG, Franz MG, Fink GS, Messina J, Fabri PJ, Gower WR, Carey LC. Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Annals of surgery. 221(6) : 625-31; discussion 631-4, 1995. http://www.ncbi.nlm.nih.gov/pubmed/7794067
  • Reintgen D, Albertini J, Berman C, Cruse CW, Fenske N, Glass LF, Puleo C, Wang X, Wells K, Rapaport D, DeConti R, Messina J, Heller R. Accurate Nodal Staging of Malignant Melanoma. Cancer control : journal of the Moffitt Cancer Center. 2(5) : 405-414, 1995. http://www.ncbi.nlm.nih.gov/pubmed/10862181
  • Glass LF, Fenske NA, Messina JL, Cruse CW, Rapaport DP, Berman C, Puleo CA, Heller R, Miliotes G, Albertini J. The role of selective lymphadenectomy in the management of patients with malignant melanoma. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 21(11) : 979-83, 1995. http://www.ncbi.nlm.nih.gov/pubmed/7582838
  • Heller R, Jaroszeski M, Leo-Messina J, Perrot R, Van Voorhis N, Reintgen D, Gilbert D. Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy Bioelectrochemistry and Bioenergetics. (36) : 83-87, 1995.
  • Norman J, Messina J, Franz M, Fabri PJ, Gower WR. Decreased Severity of Experimental Acute Pancreatitis by Pre or Post Treatment with Interleukin-1 Receptor Antagonist Gastroenterology. 106: 310-311, 1994.
  • Reintgen DS, Albertini J, Miliotis G, Berman C, Cruse CW, Fenske N, Glass F, Puleo C, Wang X, Wells K, Rapapport D, DeConti, R, Messina J, Heller R. The accurate staging and modern day treatment of malignant melanoma Cancer Research, Therapy and Control. 1: 1-15, 1994.
  • Wang X, Heller R, Cruse CW, VanVoorhis N, Glass LF, Fenske NA, Berman C, Leo-Messina J, Rapapport D, Wells K, DeConti R, Moscinski L, Stankard C, Puleo C, Reitgen DS. Detection of Submicroscopic Lymph Node Metastases with Polymerase Chain Reaction in Patients with Malignant Melanoma Annals Surg,. 220(6) : 768-774, 1994.
  • Flannery MT, Espino M, Altus P, Messina J, Wallach PM. Hodgkin's disease masquerading as sclerosing mediastinitis. Southern medical journal. 87(9) : 921-3, 1994. http://www.ncbi.nlm.nih.gov/pubmed/8091258
  • Carlan SJ, Angel JL, Leo J, Feeney J. Cephalocele involving the oral cavity Obstetrics and Gynecology. 75(3 (Pt 2)) : 494-496, 1990.
  • Sinnott JT, Multhopp H, Leo J, Rechtine G. Yersinia enterocolitica causing spinal osteomyelitis and empyema in a nonimmunocompromised host Southern Medical Journal. 82(3) : 399-400, 1989.